GlobeNewsWire
07 Jun 2026, 23:41 UTC · 14w ago
Verdict
Headline takes no side. We score 2160 +1.00 across four claims — strongly bullish.
+1.00strongly bullish
More positive than 98% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
GNI Group is acquiring 100% of Ayumi Pharmaceutical Holdings for approximately ¥44.8 billion.
More positive than 91% of claims this week
GNI Group expects combined fiscal 2026 revenue to reach approximately ¥65.2 billion following the transaction.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 84% of claims this week
GNI Group gains control of Calonal, which holds over 80% of Japan's domestic acetaminophen market.
So whatAcquiring a dominant market share in a core drug provides stable, high-moat cash flows.
More positive than 76% of claims this week
Ayumi Pharmaceutical reported ¥38.5 billion in revenue and ¥6.2 billion in operating profit for the fiscal year ended March 2026.
More positive than 64% of claims this week
Which stocks this story touches
More positive than 98% of ticker scores this week
The company is acquiring Ayumi Pharmaceutical, which is expected to substantially increase its scale, revenue, and commercial presence in Japan.
More positive than 68% of ticker scores this week
As a subsidiary of GNI Group, it benefits from the parent company's expanded scale and strategic growth in the biopharmaceutical sector.
Near neutral — 91% of ticker scores this week are stronger
Blackstone is exiting its investment in Ayumi Pharmaceutical through a sale to GNI Group.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1d ago
—
No price for 2160 right now — the quote feed didn't answer.
2160 chart →
